Chemotherapy with PCV for low grade nonenhancing oligodendrogliomas and oligoastrocytomas

被引：0
|
作者：
Soffietti, R
Rudà, R
Borgognone, M
Schiffer, D
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A423 / A424
页数：2
相关论文
共 50 条
  • [41] OLIGODENDROGLIOMAS AND MIXED OLIGOASTROCYTOMAS HAVE A HIGH INCIDENCE OF PSEUDOPROGRESSION FOLLOWING CHEMORADIOTHERAPY
    Lin, Andrew
    Liu, Jingxia
    Evans, John
    Leuthardt, Eric
    Dacey, Ralph
    Dowling, Joshua
    Kim, Albert
    Zipfel, Gregory
    Grubb, Robert
    Huang, Jiayi
    Robinson, Clifford
    Simpson, Joseph
    Linette, Gerald
    Chicoine, Michael
    David Tran
    NEURO-ONCOLOGY, 2013, 15 : 118 - 119
  • [42] PCV CHEMOTHERAPY IMMEDIATELY FOLLOWED BY RADIOTHERAPY IN DIFFUSE LOW GRADE GLIOMAS - ABOUT A SERIES OF 12 PATIENTS
    Blonski, M.
    Lacroix, C.
    Thi-Lambert, P. Nguyen
    Gauchotte, G.
    Hassani, K.
    Manceau, P.
    Ben Abdallah, M.
    Moureaux, J.
    Bastogne, T.
    Taillandier, L.
    NEURO-ONCOLOGY, 2014, 16
  • [43] Prognostic factors in children and adolescents with low-grade oligodendrogliomas
    Bowers, DC
    Mulne, AF
    Weprin, B
    Bruce, DA
    Shapiro, K
    Margraf, LR
    PEDIATRIC NEUROSURGERY, 2002, 37 (02) : 57 - 63
  • [44] Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation
    Lamba, Nayan
    McAvoy, Malia
    Kavouridis, Vasileios K.
    Smith, Timothy R.
    Touat, Mehdi
    Reardon, David A.
    Iorgulescu, J. Bryan
    NEURO-ONCOLOGY PRACTICE, 2022, 9 (03) : 201 - 207
  • [45] PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression
    Weller, Jonathan
    Katzendobler, Sophie
    Karschnia, Philipp
    Lietke, Stefanie
    Egensperger, Rupert
    Thon, Niklas
    Weller, Michael
    Suchorska, Bogdana
    Tonn, Joerg-Christian
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (02) : 283 - 291
  • [46] PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression
    Jonathan Weller
    Sophie Katzendobler
    Philipp Karschnia
    Stefanie Lietke
    Rupert Egensperger
    Niklas Thon
    Michael Weller
    Bogdana Suchorska
    Joerg-Christian Tonn
    Journal of Neuro-Oncology, 2021, 153 : 283 - 291
  • [47] Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas
    Boiardi, A
    Eoli, M
    Salmaggi, A
    Pollo, B
    Milanesi, I
    Broggi, G
    Silvani, A
    JOURNAL OF NEURO-ONCOLOGY, 2000, 49 (01) : 71 - 75
  • [48] Cisplatin and BCNU Chemotherapy for Anaplastic Oligoastrocytomas
    Amerigo Boiardi
    Marica Eoli
    Andrea Salmaggi
    Bianca Pollo
    Ida Milanesi
    Giovanni Broggi
    Antonio Silvani
    Journal of Neuro-Oncology, 2000, 49 : 71 - 75
  • [49] Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas
    Vaquero, J
    Zurita, M
    Morales, C
    Coca, S
    BRITISH JOURNAL OF NEUROSURGERY, 2001, 15 (03) : 247 - 250
  • [50] Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas
    Gerin, Chloe
    Pallud, Johan
    Deroulers, Christophe
    Varlet, Pascale
    Oppenheim, Catherine
    Roux, Francois-Xavier
    Chretien, Fabrice
    Thomas, Stephen R.
    Grammaticos, Basile
    Badoual, Mathilde
    NEURO-ONCOLOGY, 2013, 15 (10) : 1379 - 1388
12345